359 related articles for article (PubMed ID: 20028444)
1. Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis.
Coronel-Pérez IM; Rodríguez-Rey EM; Camacho-Martínez FM
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):481-5. PubMed ID: 20028444
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows.
Faghihi G; Andalib F; Asilian A
Eur J Dermatol; 2009; 19(6):586-7. PubMed ID: 19620039
[TBL] [Abstract][Full Text] [Related]
3. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.
Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH
J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023
[No Abstract] [Full Text] [Related]
4. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost.
Chiba T; Kashiwagi K; Ishijima K; Furuichi M; Kogure S; Abe K; Chiba N; Tsukahara S
Jpn J Ophthalmol; 2004; 48(2):141-7. PubMed ID: 15060793
[TBL] [Abstract][Full Text] [Related]
5. Five-year experience in the treatment of alopecia areata with DPC.
El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
Tosti A; Iorizzo M; Botta GL; Milani M
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
[TBL] [Abstract][Full Text] [Related]
7. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous latanoprost in the treatment of alopecia areata.
Mehta JS; Raman J; Gupta N; Thoung D
Eye (Lond); 2003 Apr; 17(3):444-6. PubMed ID: 12724722
[No Abstract] [Full Text] [Related]
9. Predictive model for immunotherapy of alopecia areata with diphencyprone.
Wiseman MC; Shapiro J; MacDonald N; Lui H
Arch Dermatol; 2001 Aug; 137(8):1063-8. PubMed ID: 11493099
[TBL] [Abstract][Full Text] [Related]
10. Pulse corticosteroid therapy for alopecia areata: study of 139 patients.
Nakajima T; Inui S; Itami S
Dermatology; 2007; 215(4):320-4. PubMed ID: 17911990
[TBL] [Abstract][Full Text] [Related]
11. Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata.
Ochoa BE; Sah D; Wang G; Stamper R; Price VH
J Am Acad Dermatol; 2009 Sep; 61(3):530-2. PubMed ID: 19700021
[No Abstract] [Full Text] [Related]
12. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C
J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
[TBL] [Abstract][Full Text] [Related]
13. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
Inui S; Nakajima T; Toda N; Itami S
J Dermatol; 2009 Jun; 36(6):323-7. PubMed ID: 19500180
[TBL] [Abstract][Full Text] [Related]
14. Eyelash alopecia areata: case series and literature review.
Modjtahedi BS; Kishan AU; Schwab IR; Jackson WB; Maibach HI
Can J Ophthalmol; 2012 Aug; 47(4):333-8. PubMed ID: 22883840
[TBL] [Abstract][Full Text] [Related]
15. PUVA treatment of alopecia areata.
Claudy AL; Gagnaire D
Arch Dermatol; 1983 Dec; 119(12):975-8. PubMed ID: 6651314
[TBL] [Abstract][Full Text] [Related]
16. Alopecia areata in children: treatment with diphencyprone.
Schuttelaar ML; Hamstra JJ; Plinck EP; Peereboom-Wynia JD; Vuzevski VD; Mulder PG; Oranje AP
Br J Dermatol; 1996 Oct; 135(4):581-5. PubMed ID: 8915150
[TBL] [Abstract][Full Text] [Related]
17. Alopecia areata treatment with a phototoxic dose of UVA and topical 8-methoxypsoralen.
Mohamed Z; Bhouri A; Jallouli A; Fazaa B; Kamoun MR; Mokhtar I
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):552-5. PubMed ID: 16164707
[TBL] [Abstract][Full Text] [Related]
18. Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open-label study.
Ricar J; Cetkovska P; Hordinsky M; Ricarova R
Dermatol Ther; 2022 Jun; 35(6):e15438. PubMed ID: 35278027
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of oral mega pulse methylprednisolone for severe therapy resistant Alopecia areata.
Bin Saif GA; Al-Khawajah MM; Al-Otaibi HM; Al-Roujayee AS; Alzolibani AA; Kalantan HA; Al-Sheikh OA; Arafah MM
Saudi Med J; 2012 Mar; 33(3):284-91. PubMed ID: 22426909
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata.
Kim BJ; Min SU; Park KY; Choi JW; Park SW; Youn SW; Park KC; Huh CH
J Dermatolog Treat; 2008; 19(4):216-20. PubMed ID: 18608727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
